Concerning to the embolization for the intracranial aneurysms, the underlying theme of the discussion is presented with our experiences.
Introduction
The surgical clipping based on the development of microsurgical technique has long been a gold standard for the treatment of intracranial aneurysms. However, for patients with surgical difficulty due to the location of aneurysms or medical condition, other methods of treatment were reported in the literature including the use of detachable balloons, push able microcoils, interlocking detachable coils and liquid embolic agents to occlude intracranial aneurysms with preservation of the parent artery.
In 1991 and 1992, Guglielmi and colleagues reported the use of detachable platinum microcoils to occlude intracranial aneurysms (Guglielmi Detachable Coil: GDC) 2,3. These microcoils are deposited in the aneurysm and detached by means of electrolysis and electrothrombosis. This endovascular technique offers a controllable and delicate occlusion of the aneurysm. At present, more than 10,000 patients around the world have profited for this technique alone or in combination with neurosurgical therapeutic modalities. In Japan, GDC was used clinically from March 1997. In this paper, I want to write the underlying theme for the endovascular treatment of intracranial aneurysms as presently practiced in Japan.
Unruptured aneurysm
Due to the rising popularity of preventative medicme in Japan, the number of unruptured aneurysms detected is increasing. In several reports, it has been suggested that the frequency of intracranial aneurysms in the general population ranges 2 to 5 percent 4. The management of uoruptured intracranial AN is controversial because of a lack of understanding of the natural history of these lesions and the risks of repairing them. The issues by Wiebers et al in 1998 was very shocking 8. They concluded that the likelihood of rupture of unruptured intracranial aneurysms that were less than 10 mm in diameter was exccedingly low (0.05 percent per year) among patients in group 1 (the patients had no history of subarachnoid hemorrhage from a different aneurysm) and was substantially higher among tiose in group 2 (the patients had a history of subarachnoid hem orrhage from a different aneurysm that have been repaired successfully). The risk of morbidity and mortality related to surgery greatly exceeded the 7.5-Year risk of rupture among patients in group I with unruptured intracranial aneurysms smaller than 10 mm in diameter. Immediately many counter arguments have been described in many literature to concern the bias of aneurysm distribution that they included too much intracavernous aneurysms and of the relation between subarachnoid hemorrhage and the size of the aneurysm. Anyway, There is a certain risk of GDC treatment for umruptured aneurysm. This treatment of unruptured aneurysms cam only be indicated if the risk of natural history of the disease is higher than the risk of an therapeutic management. By Murayama et A1 7 , in the report on 115 unruptured aneurysm cases which were treated by GDC, it was concluded that a satisfactory embolization was achieved in 91 % of aneurysms with 8 patients having immediate procedural complications, most of these were in the first 50 cases. In our experiences from March 1997, there were no mortality and a morbidity in 44 cases. A patient of IC-Ophthalmic aneurysm complained 114 visual field defect in the affected side aLter the embolization. The efficacy of GDC treatment of intracranial aneurysms ha been established. However there remains several factors which hindered optimal coiling include the following: wide aneurysm neck in relation to the overall aneurysm size, mural thrombus, giant aneurysm, arteries originating from the aneurysm sac, and middle cerebral location 1.
Ruptured aueurysm
The primary object of ruptured aneurysm treatment is to prevent the re-rupture. Current several reports have shown that embolization is more beneficial than surgical clipping in terms of the less invasive approach. In our department, GDC embolization is the first choice treatment for cerebral aneurysms under the following conditions; the aneurysm is less than 15 mm and larger than 3 mm with clear neck, no intracranial hematoma and no severe atherosclerotic change. Anatomical and angiographical configuration is very important for successful embolization 5. As a results of GDC embolization for ruptured aneurysms in seventy nine cases, sixty-two patients (78%) were independent (GR or MD) on discharge. Among the patients of Hunt and Hess Grade I, 11 and Ill, forty eight patients (96%) were independent. Concerning the aneurysmal occlusion immediately after initial embolization, 22 aneurysms (28%) demonstrated complete occlusion and 12 (16%) aneurysms demonstrated neck remnant, whereas 44 aneurysms (56%) exhibited body filling. Surgical clipping after embolization was performed in 6 cases (7%) and additional embolization was performed in 10 cases (13%). In the follow-up period (at least 3 month alter initial embolization), 46 aneurysms (59%) exhibited complete occlusion, 22 (28%) neck rem-M. Sonobe nant and 11 (14%) body filling. Symptomatic complication related to the procedures was 4 % as the permanent morbidity and 1.2 % as the mortality. Two elder patients (80 and 74 years old) with severe atherosclerotic change of proximal vessels suffered from re-rupture of body filling aneurysms in acute period. Direct removal of clot is impossible for endovascular treatment of aneurysms. Therefore, we placed spinal drainage for all patients in principle and administered tPA to patients with thick clot in order to remove clot for prevention of vasospasm. Symptomatic vasospasm was evaluated by neurological examination and cerebral angiography in 69 patients.
Symptomatic vasospasm occurred in seven patients (10%) and three patients required chemical or mechanical angioplasty. Permanent morbidity due to vasospasm occurred in two patient (2.8%). There was no death related to vasospasm. Murayama et Al reported symptomatic spasm in 23 %, permanent morbidity in 2.9% and mortality in 2.9%. Debrun et Al reported 22% symptomatic spasm, 3.6% permanent morbidity and 5.3% mortality. Our result shows the lowest incidence of symptomatic vasospasm. we think that endovascular treatment does not have adverse effect on vasospasm. Continuous drainage of bloody cerebrospinal fluid and intrathecal administration of tPA for facilitating clot lysis might decrease the incidence and severity of vasospasm atter subarachnoid hemorrhage.
Cost of GDC treatment
It is very diff'cult to standardize the cost of the medical treatment because it depends on the individual patient's condition. To study the financial cost, the amounts paid on discharge were cheeked, in Japan this does not include the wages of medical staff. The difference between the cost of GDC treatment and surgical clipping for aneurysms was compared usimg only the most simple cases and excluding technical and medical complications. In unruptured cases, the total payment was 1460000 yen for a GDC treated case and 1410000 yen for a surgical clipped case. The hospital stay was 8 days in the GDC case and 19 days in the surgical case. Although the technical fee is cheaper in GDC treatment (26200 yen) than that in surgical clipping (721000 yen), the unit cost of the coil is ex-orbitantly expensive (over 130000 yen). A similar state of affairs can be found in ruptured cases. By the GDC treatment, the hospital stay is short and the technical fee is cheap, however the total difference in price between the GDC treatment (2580000 yen) amd surgical clipping (2870000 yen) is not so big.
Discussion
GDC was used clinically from March 1997 in Japan. The number of treated intracranial aneurysms were estimated 23500 in 1997,25500 in 1998, and 27500 in 1999 in Japan and the number of GDC embolizations were registered 1230 (5%) in 1997,2070 (8%) in 1998, and 2750 (10%) in 1999. This percentage is now lower than that in the Europe (25 % ) and USA (16%), but will change more with increasing public awareness of the effcacy of GDC treatment for aneurysms. The reason for expansion of GDC treatment may be that the patients favor the less invasive therapy that it represents. This procedure can be performed with only one cutaneous puncture, shorter time until ambulation and discharge. Further, this approach does not involve dissection or isolation of small vessels and nerves adhering to the aneurysmal sac or a risk of mechanical damage to surrounding normal tissues frequently associated with surgical maneuver, because it treats the aneurysm in isolation from external structures. Recently it is confirmed that the GDC treatment is less invasive by the evaluation of the energy change, production of neuron specific enolase, regional cerebral blood flow and edematous change in diffusion MRI after GDC treatment and surgical clipping. However, the long-term outcome of this type of treatment is not well defined. Long-term follow-up should be continued after embolization for comparison with establisEed clipping techniques, although intermediate term results of coil embolization have! been published. The risks of this treatment need to be less than other alternatives. In the questionnaire survey of the endovascular treatment of aneurysm with GDC in Japan in 1998, 86 (8.6%) symptomatic complications was reported in 996 of the total registered cases. Especially, perforation of aneurysm during embolization were 47 (4.7%) in which 19 was symptomatic including 11 death. It was a initial date concerning to the GDC treatment in Japan. As Interventional Neuroradiology 6 (Suppll): 71-73,2000 described in several reports, there is a learning curve and this treatment may become easier and less risky in future. New technique and devices are being developed which may reduce the risk of endovascular treatment for aneurysm including the three dimensional DSA, the three-dimensional coil, the re-modeling method using balloon assistance 6 and combined stent-coil procedures.
Conclusions
In conclusion, GDC treatment is convinced to be efficient and satety from many supportive reports and our experiences. Over 70% of the intracranial aneurysms can be treated by GDC treatment or surgical clipping. The decision of the first choice treatment for these aneurysms depends on the skillfulness of the operator and the philosophy of each institution.
